DE3764697D1 - T-pa enthaltende medizinische zubereitung und deren verwendung. - Google Patents

T-pa enthaltende medizinische zubereitung und deren verwendung.

Info

Publication number
DE3764697D1
DE3764697D1 DE8787104825T DE3764697T DE3764697D1 DE 3764697 D1 DE3764697 D1 DE 3764697D1 DE 8787104825 T DE8787104825 T DE 8787104825T DE 3764697 T DE3764697 T DE 3764697T DE 3764697 D1 DE3764697 D1 DE 3764697D1
Authority
DE
Germany
Prior art keywords
preparation containing
medical preparation
medical
meglumine
tpa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787104825T
Other languages
English (en)
Inventor
Fumio Kakimoto
Naoki Asakawa
Yasuo Ishibashi
Yasuo Miyake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of DE3764697D1 publication Critical patent/DE3764697D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49Urokinase; Tissue plasminogen activator
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE8787104825T 1986-04-02 1987-04-01 T-pa enthaltende medizinische zubereitung und deren verwendung. Expired - Fee Related DE3764697D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP61074370A JPH0678241B2 (ja) 1986-04-02 1986-04-02 tPA医薬組成物

Publications (1)

Publication Number Publication Date
DE3764697D1 true DE3764697D1 (de) 1990-10-11

Family

ID=13545204

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787104825T Expired - Fee Related DE3764697D1 (de) 1986-04-02 1987-04-01 T-pa enthaltende medizinische zubereitung und deren verwendung.

Country Status (8)

Country Link
US (1) US4985245A (de)
EP (1) EP0242653B1 (de)
JP (1) JPH0678241B2 (de)
AT (1) ATE56147T1 (de)
CA (1) CA1289472C (de)
DE (1) DE3764697D1 (de)
ES (1) ES2031846T3 (de)
GR (1) GR3000751T3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2520975B2 (ja) * 1989-09-21 1996-07-31 三井東圧化学株式会社 組織プラスミノ―ゲンアクチベ―タ―若しくはその誘導体を含有する血栓溶解剤
DE3942141A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh K2p pro-stabilisierung
DE3942143A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh T-pa pro stabilisierung
DE3942142A1 (de) * 1989-12-20 1991-06-27 Boehringer Mannheim Gmbh Stabilisierung von glykosyliertem t-pa
GB0007239D0 (en) * 2000-03-24 2000-05-17 Nycomed Imaging As Use
JP5468221B2 (ja) * 2008-08-04 2014-04-09 株式会社 メドレックス 難溶性薬物の静注用分散製剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5137343B2 (de) * 1972-12-07 1976-10-15
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3584902D1 (de) * 1984-02-29 1992-01-30 Asahi Chemical Ind Waessrige loesung eines darin in erhoehter konzentration aufgeloesten gewebe-plasminogen-aktivators und herstellungsverfahren.

Also Published As

Publication number Publication date
JPH0678241B2 (ja) 1994-10-05
GR3000751T3 (en) 1991-10-10
CA1289472C (en) 1991-09-24
ES2031846T3 (es) 1996-07-16
EP0242653B1 (de) 1990-09-05
US4985245A (en) 1991-01-15
EP0242653A1 (de) 1987-10-28
ATE56147T1 (de) 1990-09-15
JPS62234030A (ja) 1987-10-14

Similar Documents

Publication Publication Date Title
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
ATE70191T1 (de) Knochenzement zur kontrollierten abgabe von wirkstoffen.
AU563557B2 (en) Photochemical decontamination treatment of whole blood or blood components
EP0151989A3 (en) Means for the treatment of cardiac diseases
DE3888012D1 (de) Substituierte 4-[1H-Imidazol-1-yl]benzamide als antiarrhythmische Mittel.
DE3764697D1 (de) T-pa enthaltende medizinische zubereitung und deren verwendung.
DE69024382D1 (de) Fledermausspeichel-Plasminogenaktivator vPA-alpha 1
ATE120962T1 (de) Antithrombin-lösung und ihre verwendung.
SE8400723D0 (sv) Farmaceutisk komposition
AU3024389A (en) Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants
HUT47221A (en) Process for production of medical compositions containing as active substance human xiii factor
AU584548B2 (en) Sterilization of adsorbent and column having improved storability including sterilized adsorbent for use in extracorporeal circulation treatment
ES2094757T3 (es) Un factor megacariocitopoyetico.
NO901995D0 (no) Ny variant av human vevtypeplasminogenaktivator.
ES2077698T3 (es) Agente terapeutico para la gangrena diabetica.
DK277387A (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
FI883177A (fi) Anvaendning av ett medium med hoeg affinitet foer tumoerer.
ATE136776T1 (de) Verwendung von heptastigmin zur behandlung der zerebralen ictus
ATE72397T1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee